Actavis proposes deal to acquire Pliva of Croatia

Article Abstract:

Actavis Group H.F. of Iceland has offered an acquisition bid of $1.6 billion for Pliva DD of Croatia. The generic pharmaceutical company responded that it "does not believe that the proposal adequately reflects the fundamental value and future prospects of the company." The takeover would create the third largest generic pharmaceutical company in the world by sales.

Iceland, Company overview, Industry overview

---

Roche to acquire Ventana for $3.4 billion

Article Abstract:

Swiss pharmaceutical firm Roche Holding Ltd. has bought US medical equipment and diagnostics company Ventana Medical Systems Inc. for $3.4 bil. Ventana's board agreed to the offer after Roche raised it by 19%. The deal represents a 72% premium at $89.50 per share.

Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Medical Instruments & Supplies, Switzerland, Medical equipment and supplies industry, Medical equipment industry, Roche Holding Ltd., Medical test kit industry, Ventana Medical Systems Inc., VMSI

---

Actavis sweetens offer for Pliva, creating turbulence for Barr bid

Article Abstract:

The generic drugmaker Actavis Group H.F. has sweetened its offer for Pliva DD of Croatia to $2.3 billion. Pliva DD had just accepted an acquisition offer from Barr Pharmaceuticals Inc. of the United States for $2.2 billion.

United States

Similar abstracts:

• Abstracts: Albertson's buyout deal collapses. SunGard announces deal as field of targets shrinks for bulging buyout funds
• Abstracts: UniCredito agrees to acquire HVB. Linde garners approval of FTC for its Acquisition of BOC Group
• Abstracts: Veolia stays open to acquisitions; net jumps 59%. Write-down of U.S. filter unit leads to first-half net loss
• Abstracts: LVMH is nearing sale of Omas pen business. L'Oreal is looking to buy Indian brand. Prada sells Helmut Lang brand to Japan's Link Theory Holding

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.